Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
Cancer|October 3, 2023
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancerRamez Philips, Angela Alnemri, Dev Amin, et al.JAMA Otolaryngology-- Head & Neck Surgery|July 9, 2023
Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell CarcinomaDev R Amin, Ramez Philips, Dylan G Bertoni, et al.JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant NivolumabAnnie E Moroco, Kathryn Nunes, Angela Alnemri, et al.Head & Neck|June 21, 2020
COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizonEvan Graboyes, John Cramer, Karthik Balakrishnan, et al.The Laryngoscope|December 16, 2015
Multicompartment metabolism in papillary thyroid cancerJoseph M Curry, Patrick Tassone, Paolo Cotzia, et al.Journal for Immunotherapy of Cancer|August 3, 2023
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neckJennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, et al.Oral Oncology|January 20, 2026
Accuracy of frozen section for HPV-Associated squamous cell carcinoma of unknown primarySindhura Sridhar, Annie Moroco, Shravan Gowrishankar, et al.Cancer Medicine|June 7, 2024
Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinomaAngela E Alnemri, Sruti Tekumalla, Annie E Moroco, et al.Frontiers in Oncology|December 21, 2020
Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment EffectDante J Merlino, Jennifer M Johnson, Madalina Tuluc, et al.Head & Neck|June 6, 2022
Analysis of cost and outcomes in bony versus soft tissue midface free flap reconstructionAngela Alnemri, Ramez Philips, Sarah Sussman, et al.Pageof 10